vs
亚什兰（ASH）与Freedom Holding Corp.（FRHC）财务数据对比。点击上方公司名可切换其他公司
Freedom Holding Corp.的季度营收约是亚什兰的1.6倍（$628.6M vs $386.0M），Freedom Holding Corp.净利率更高（12.1% vs -3.1%，领先15.2%），Freedom Holding Corp.同比增速更快（-4.1% vs -4.7%），Freedom Holding Corp.自由现金流更多（$651.7M vs $111.0M），过去两年Freedom Holding Corp.的营收复合增速更高（16.3% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Freedom Holding Corp.是在美国内华达州注册的投资集团，业务覆盖零售证券经纪交易、资产管理、资本市场服务、投研咨询、投行承销、抵押贷款、保险、银行及其他消费金融服务，核心布局美股、欧洲及以哈萨克斯坦为核心的中亚市场。
ASH vs FRHC — 直观对比
营收规模更大
FRHC
是对方的1.6倍
$386.0M
营收增速更快
FRHC
高出0.6%
-4.7%
净利率更高
FRHC
高出15.2%
-3.1%
自由现金流更多
FRHC
多$540.7M
$111.0M
两年增速更快
FRHC
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $628.6M |
| 净利润 | $-12.0M | $76.2M |
| 毛利率 | 27.2% | 96.0% |
| 营业利润率 | -1.6% | 14.9% |
| 净利率 | -3.1% | 12.1% |
| 营收同比 | -4.7% | -4.1% |
| 净利润同比 | 92.7% | -2.6% |
| 每股收益（稀释后） | $-0.26 | $1.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHFRHC
| Q4 25 | $386.0M | $628.6M | ||
| Q3 25 | $477.0M | $526.1M | ||
| Q2 25 | $463.0M | $533.4M | ||
| Q1 25 | $479.0M | $363.7M | ||
| Q4 24 | $405.0M | $655.2M | ||
| Q3 24 | $521.0M | $580.9M | ||
| Q2 24 | $544.0M | $450.7M | ||
| Q1 24 | $575.0M | $464.7M |
净利润ASHFRHC
| Q4 25 | $-12.0M | $76.2M | ||
| Q3 25 | $31.0M | $38.7M | ||
| Q2 25 | $-742.0M | $30.4M | ||
| Q1 25 | $31.0M | $-142.7M | ||
| Q4 24 | $-165.0M | $78.3M | ||
| Q3 24 | $17.0M | $114.7M | ||
| Q2 24 | $6.0M | $34.4M | ||
| Q1 24 | $120.0M | $95.2M |
毛利率ASHFRHC
| Q4 25 | 27.2% | 96.0% | ||
| Q3 25 | 33.3% | 97.1% | ||
| Q2 25 | 28.5% | 97.4% | ||
| Q1 25 | 30.7% | 96.6% | ||
| Q4 24 | 27.4% | 98.6% | ||
| Q3 24 | 33.2% | 99.1% | ||
| Q2 24 | 34.2% | 99.0% | ||
| Q1 24 | 28.0% | — |
营业利润率ASHFRHC
| Q4 25 | -1.6% | 14.9% | ||
| Q3 25 | 12.8% | 11.5% | ||
| Q2 25 | -152.9% | 7.6% | ||
| Q1 25 | 10.6% | -42.7% | ||
| Q4 24 | -44.2% | 15.0% | ||
| Q3 24 | 6.1% | 22.1% | ||
| Q2 24 | -11.2% | 9.2% | ||
| Q1 24 | 3.7% | 22.5% |
净利率ASHFRHC
| Q4 25 | -3.1% | 12.1% | ||
| Q3 25 | 6.5% | 7.4% | ||
| Q2 25 | -160.3% | 5.7% | ||
| Q1 25 | 6.5% | -39.2% | ||
| Q4 24 | -40.7% | 11.9% | ||
| Q3 24 | 3.3% | 19.7% | ||
| Q2 24 | 1.1% | 7.6% | ||
| Q1 24 | 20.9% | 20.5% |
每股收益（稀释后）ASHFRHC
| Q4 25 | $-0.26 | $1.25 | ||
| Q3 25 | $0.83 | $0.63 | ||
| Q2 25 | $-16.21 | $0.50 | ||
| Q1 25 | $0.65 | $-2.35 | ||
| Q4 24 | $-3.50 | $1.29 | ||
| Q3 24 | $0.34 | $1.89 | ||
| Q2 24 | $0.12 | $0.57 | ||
| Q1 24 | $2.39 | $1.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $869.2M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $1.4B |
| 总资产 | $4.5B | $12.4B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHFRHC
| Q4 25 | $304.0M | $869.2M | ||
| Q3 25 | $215.0M | $636.0M | ||
| Q2 25 | $207.0M | $567.9M | ||
| Q1 25 | $168.0M | $837.3M | ||
| Q4 24 | $219.0M | $577.9M | ||
| Q3 24 | $300.0M | $569.2M | ||
| Q2 24 | $399.0M | $718.7M | ||
| Q1 24 | $439.0M | $545.1M |
总债务ASHFRHC
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
股东权益ASHFRHC
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.9B | $1.2B | ||
| Q2 25 | $1.9B | $1.2B | ||
| Q1 25 | $2.6B | $1.2B | ||
| Q4 24 | $2.6B | $1.3B | ||
| Q3 24 | $2.9B | $1.3B | ||
| Q2 24 | $3.0B | $1.1B | ||
| Q1 24 | $3.1B | $1.2B |
总资产ASHFRHC
| Q4 25 | $4.5B | $12.4B | ||
| Q3 25 | $4.6B | $10.3B | ||
| Q2 25 | $4.6B | $9.7B | ||
| Q1 25 | $5.2B | $9.9B | ||
| Q4 24 | $5.2B | $9.1B | ||
| Q3 24 | $5.6B | $8.8B | ||
| Q2 24 | $5.7B | $8.5B | ||
| Q1 24 | $5.9B | $8.3B |
负债/权益比ASHFRHC
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $717.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $651.7M |
| 自由现金流率自由现金流/营收 | 28.8% | 103.7% |
| 资本支出强度资本支出/营收 | 3.6% | 10.5% |
| 现金转化率经营现金流/净利润 | — | 9.42× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHFRHC
| Q4 25 | $125.0M | $717.8M | ||
| Q3 25 | $40.0M | $535.3M | ||
| Q2 25 | $115.0M | $480.8M | ||
| Q1 25 | $9.0M | $1.3B | ||
| Q4 24 | $-30.0M | $-72.8M | ||
| Q3 24 | $80.0M | $-438.0M | ||
| Q2 24 | $127.0M | $854.1M | ||
| Q1 24 | $54.0M | $309.0M |
自由现金流ASHFRHC
| Q4 25 | $111.0M | $651.7M | ||
| Q3 25 | $6.0M | $456.4M | ||
| Q2 25 | $95.0M | $450.0M | ||
| Q1 25 | $-12.0M | — | ||
| Q4 24 | $-53.0M | $-92.7M | ||
| Q3 24 | $42.0M | $-447.5M | ||
| Q2 24 | $98.0M | $829.9M | ||
| Q1 24 | $20.0M | — |
自由现金流率ASHFRHC
| Q4 25 | 28.8% | 103.7% | ||
| Q3 25 | 1.3% | 86.7% | ||
| Q2 25 | 20.5% | 84.4% | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | -13.1% | -14.1% | ||
| Q3 24 | 8.1% | -77.0% | ||
| Q2 24 | 18.0% | 184.1% | ||
| Q1 24 | 3.5% | — |
资本支出强度ASHFRHC
| Q4 25 | 3.6% | 10.5% | ||
| Q3 25 | 7.1% | 15.0% | ||
| Q2 25 | 4.3% | 5.8% | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.7% | 3.0% | ||
| Q3 24 | 7.3% | 1.6% | ||
| Q2 24 | 5.3% | 5.4% | ||
| Q1 24 | 5.9% | — |
现金转化率ASHFRHC
| Q4 25 | — | 9.42× | ||
| Q3 25 | 1.29× | 13.82× | ||
| Q2 25 | — | 15.82× | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | -0.93× | ||
| Q3 24 | 4.71× | -3.82× | ||
| Q2 24 | 21.17× | 24.83× | ||
| Q1 24 | 0.45× | 3.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
FRHC
暂无分部数据
